Table 3.
Risk factors for mortality from symptomatic PIV infections
| Characteristic | Mortality | p-value | |
|---|---|---|---|
| Yes n=6 |
No n=40 |
||
| African-American race | 4 | 5 | 0.013 |
| White | 2 | 28 | |
| Other | 0 | 7 | |
| LRTI | 6 | 12 | 0.002 |
| URTI | 0 | 28 | |
| Mechanical ventilation | 6 | 0 | <0.0001 |
| No mechanical ventilation | 0 | 40 | |
| Use of steroids prior to infection | 5 | 4 | <0.0001 |
| No steroids prior to infection | 1 | 36 | |
| ALC<100 cells/μL | 5 | 10 | 0.01 |
| ALC>100 cells/μL | 1 | 30 | |
PIV, parainfluenza; LRTI, lower respiratory tract infection; URTI, upper respiratory tract infection; ALC, absolute lymphocyte count.